- Success Stories
Accelerating results in clinical trials means the structure and functionality of operations is changing. Flat CROs are replacing long vertical ones as new areas of specialization are emerging. Now, operational, planning and end-to-end functional experts account for much of the innovation in clinical trials and most importantly, speed and process improvements.
Immuno-oncology is the forefront of using the unique biology of each patient to cure themselves. Subsequently, our oncology experts have had a substantial and growing impact on this rapidly evolving field. With new drugs being approved for multiple indications and combination therapies, challenges have never been greater.
Our immuno-oncology clients have developed vaccines, t-cell therapies, and first-in-class treatments. They have used our development and regulatory strategists and medical and operational specialists as consultants on a wide range of program initiatives.
For instance, when: